The data suggest that moderate DKK1 concentrations were sufficient to inhibit MS and therefore stem cell-like activity in both ER+ve and ER−ve tumours whilst not affecting the activity within normal breast tissue. This evidence concerns the gene DKK1 and neoplasm.